Anticancer Therapy
Recent developments in antitumor taxoids reviewed
Published in Medical Letter on the CDC and FDA, February 15th, 2004
"Since the Food and Drug Administration approval of paclitaxel (Taxol, Bristol-Myers Squibb) and docetaxel (Taxotere, Rhone-Poulenc Rorer SA, now Aventis) as anticancer drugs, a number of new analogues have been prepared with the view of obtaining taxoids with better potency and bioavailability to targeted cells, as well as taxoids efficient in targeting multi-drug resistant cancer or taxoids acting as modulators of multi-drug resistance (MDR)," investigators in France report.
"Studies have also been performed in the search...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Meningitis
Echovirus type 13 emerging as prominent enterovirus - Adolescent Health
Survey finds 8,000 clandestine abortions occur yearly in Burkina Faso capital - Alzheimer Disease
Namenda now available nationwide - Amyotrophic Lateral Sclerosis
AEOL 10150 clears toxicology hurdle; company makes initial draw on financing - Animal Models
Diets with different levels of soy affect toxicity assessments in rats - Avian Influenza
Vietnam last on vaccine list - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
